Erasca to discuss phase 1 data for RAS cancer drug ERAS-0015

April 27, 2026 8:30 AM

Erasca Inc. (NASDAQ: ERAS) announced it will host a conference call and webcast on April 27, 2026, at 4:30 p.m ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found